These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25008041)

  • 1. The social environment and illness uncertainty in chronic obstructive pulmonary disease.
    Hoth KF; Wamboldt FS; Ford DW; Sandhaus RA; Strange C; Bekelman DB; Holm KE
    Int J Behav Med; 2015 Apr; 22(2):223-32. PubMed ID: 25008041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective impact of illness uncertainty on outcomes in chronic lung disease.
    Hoth KF; Wamboldt FS; Strand M; Ford DW; Sandhaus RA; Strange C; Bekelman DB; Holm KE
    Health Psychol; 2013 Nov; 32(11):1170-4. PubMed ID: 23772888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD.
    Holm KE; Borson S; Sandhaus RA; Ford DW; Strange C; Bowler RP; Make BJ; Wamboldt FS
    COPD; 2013 Apr; 10(2):226-34. PubMed ID: 23547634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of age on outcomes in chronic obstructive pulmonary disease differs by relationship status.
    Holm KE; Plaufcan MR; Ford DW; Sandhaus RA; Strand M; Strange C; Wamboldt FS
    J Behav Med; 2014 Aug; 37(4):654-63. PubMed ID: 23645147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prospective association of perceived criticism with dyspnea in chronic lung disease.
    Holm KE; Wamboldt FS; Ford DW; Sandhaus RA; Strand M; Strange C; Hoth KF
    J Psychosom Res; 2013 May; 74(5):450-3. PubMed ID: 23597335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease: A Family Perspective.
    Anzueto A
    COPD; 2015 Aug; 12(4):462-7. PubMed ID: 25474273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions.
    Weldam SW; Lammers JW; Heijmans MJ; Schuurmans MJ
    BMC Fam Pract; 2014 Aug; 15():140. PubMed ID: 25087008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States.
    Sieluk J; Slejko JF; Silverman H; Perfetto E; Mullins CD
    Orphanet J Rare Dis; 2020 Sep; 15(1):260. PubMed ID: 32967697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol use predicts ER visits in individuals with alpha-1 antitrypsin deficiency (AATD) associated COPD.
    Hoth KF; Ford DW; Sandhaus RA; Strange C; Wamboldt FS; Holm KE
    COPD; 2012 Aug; 9(4):417-25. PubMed ID: 22651849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics associated with SF-36 in alpha-1 antitrypsin deficiency-associated COPD: a cross-sectional analysis.
    Choate R; Holm KE; Sandhaus RA; Mannino DM; Strange C
    BMC Pulm Med; 2024 Mar; 24(1):138. PubMed ID: 38500152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.
    Tural Onur S; Natoli A; Dreger B; Arınç S; Sarıoğlu N; Çörtük M; Karadoğan D; Şenyiğit A; Yıldız BP; Köktürk N; Argun Barıs S; Kodalak Cengiz S; Polatli M
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2785-2794. PubMed ID: 38046982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency.
    Manca S; Rodriguez E; Huerta A; Torres M; Lazaro L; Curi S; Pirina P; Miravitlles M
    COPD; 2014 Sep; 11(5):480-8. PubMed ID: 24832005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
    Karl FM; Holle R; Bals R; Greulich T; Jörres RA; Karch A; Koch A; Karrasch S; Leidl R; Schulz H; Vogelmeier C; Wacker ME;
    Respir Res; 2017 Apr; 18(1):60. PubMed ID: 28416015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD.
    Balbi B; Sangiorgi C; Gnemmi I; Ferrarotti I; Vallese D; Paracchini E; Delle Donne L; Corda L; Baderna P; Corsico A; Carone M; Brun P; Cappello F; Ricciardolo FL; Ruggeri P; Mumby S; Adcock IM; Caramori G; Di Stefano A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1879-1893. PubMed ID: 31686800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency.
    Jarosch I; Hitzl W; Koczulla AR; Wencker M; Welte T; Gloeckl R; Janciauskiene S; Kenn K
    Respir Med; 2017 Sep; 130():98-101. PubMed ID: 29206641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after lung transplantation in recipients with alpha-1-antitrypsin deficiency compared to other forms of chronic obstructive pulmonary disease: a national cohort study.
    Gulack BC; Mulvihill MS; Ganapathi AM; Speicher PJ; Chery G; Snyder LD; Davis RD; Hartwig MG
    Transpl Int; 2018 Jan; 31(1):45-55. PubMed ID: 28833662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day-to-day living with severe chronic obstructive pulmonary disease: towards a family-based approach to the illness impacts.
    Gabriel R; Figueiredo D; Jácome C; Cruz J; Marques A
    Psychol Health; 2014; 29(8):967-83. PubMed ID: 24617821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.